{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:839af13f-4847-4be6-a178-b529f6207475","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T22:31:36.403993+00:00","published_at":"2026-10-16T13:53:41.002909+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:vai8qa1pz7mfc","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-12","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:sarah-nemec","alpha:company:839af13f-4847-4be6-a178-b529f6207475"],"caused_claim_ids":["alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:58c20d7717310668f09baa4b44806748d5f1a279efab2113219a3597af0f3366"],"summary":"Sarah Nemec executive of Bolt Biotherapeutics, Inc., effective 2026-03-12.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:cxdccuggjnki","event_type":"CEO_CHANGED","effective_at":"2026-03-12","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:william-p-quinn","alpha:company:839af13f-4847-4be6-a178-b529f6207475"],"caused_claim_ids":["alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:cbc4ae8ef667dcb810ba9d0421558abda09b08112a0d6bf9578d6b09eccd9710"],"summary":"William P. Quinn executive of Bolt Biotherapeutics, Inc., effective 2026-03-12.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:14vsknfdcayf3","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:jakob-dupont-m-d","alpha:company:839af13f-4847-4be6-a178-b529f6207475"],"caused_claim_ids":["alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d"],"summary":"Jakob Dupont, M.D. seat on Bolt Biotherapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:k6yzrj1uj353j","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:laura-berner","alpha:company:839af13f-4847-4be6-a178-b529f6207475"],"caused_claim_ids":["alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d"],"summary":"Laura Berner seat on Bolt Biotherapeutics, Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:12ok9b59uota3","event_type":"COMMITTEE_CREATED","effective_at":"2022-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:committee:bolt-biotherapeutics-inc:audit-nominating-and-governance-chair","alpha:company:839af13f-4847-4be6-a178-b529f6207475"],"caused_claim_ids":["alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d"],"summary":"Audit; Nominating and Governance · Chair committee of Bolt Biotherapeutics, Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:v7y90x12myrkp","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2022-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:laura-berner","alpha:committee:bolt-biotherapeutics-inc:audit-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d"],"summary":"Laura Berner member of Audit; Nominating and Governance · Chair, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:9fes2n2npmzp","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:brian-o-callaghan","alpha:company:839af13f-4847-4be6-a178-b529f6207475"],"caused_claim_ids":["alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d"],"summary":"Brian O'Callaghan seat on Bolt Biotherapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:suz0l11jl1px9","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:nicole-onetto-m-d","alpha:company:839af13f-4847-4be6-a178-b529f6207475"],"caused_claim_ids":["alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d"],"summary":"Nicole Onetto, M.D. seat on Bolt Biotherapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1flkluc94phl2","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:kathleen-laporte","alpha:company:839af13f-4847-4be6-a178-b529f6207475"],"caused_claim_ids":["alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d"],"summary":"Kathleen LaPorte seat on Bolt Biotherapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:yhywtg1de1y9i","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:committee:bolt-biotherapeutics-inc:audit-chair-compensation","alpha:company:839af13f-4847-4be6-a178-b529f6207475"],"caused_claim_ids":["alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d"],"summary":"Audit · Chair; Compensation committee of Bolt Biotherapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:14io11ho6yxwv","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:53:41.002909+00:00","subject_ids":["alpha:person:kathleen-laporte","alpha:committee:bolt-biotherapeutics-inc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d"],"summary":"Kathleen LaPorte member of Audit · Chair; Compensation, effective 2020-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:5","subject_id":"alpha:company:839af13f-4847-4be6-a178-b529f6207475","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:brian-o-callaghan","object_label":"Brian O'Callaghan","object_source_name_forms":[],"value":"Brian O'Callaghan: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:brian-o-callaghan","name":"Brian O'Callaghan"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Bolt Biotherapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000095017025058632/bolt-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:46:01.19+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:6","subject_id":"alpha:company:839af13f-4847-4be6-a178-b529f6207475","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jakob-dupont-m-d","object_label":"Jakob Dupont, M.D.","object_source_name_forms":[],"value":"Jakob Dupont, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jakob-dupont-m-d","name":"Jakob Dupont, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Bolt Biotherapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000095017025058632/bolt-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:46:01.19+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:7","subject_id":"alpha:company:839af13f-4847-4be6-a178-b529f6207475","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kathleen-laporte","object_label":"Kathleen LaPorte","object_source_name_forms":[],"value":"Kathleen LaPorte: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kathleen-laporte","name":"Kathleen LaPorte"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Bolt Biotherapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000095017025058632/bolt-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:46:01.19+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:8","subject_id":"alpha:company:839af13f-4847-4be6-a178-b529f6207475","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:laura-berner","object_label":"Laura Berner","object_source_name_forms":[],"value":"Laura Berner: Director, Audit; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:laura-berner","name":"Laura Berner"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Bolt Biotherapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000095017025058632/bolt-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:46:01.19+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:9","subject_id":"alpha:company:839af13f-4847-4be6-a178-b529f6207475","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:nicole-onetto-m-d","object_label":"Nicole Onetto, M.D.","object_source_name_forms":[],"value":"Nicole Onetto, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:nicole-onetto-m-d","name":"Nicole Onetto, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Bolt Biotherapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000095017025058632/bolt-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:46:01.19+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:11","subject_id":"alpha:company:839af13f-4847-4be6-a178-b529f6207475","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:sarah-nemec","object_label":"Sarah Nemec","object_source_name_forms":[],"value":"Sarah Nemec: Senior Vice President, Finance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:sarah-nemec","name":"Sarah Nemec"},"title":"Senior Vice President, Finance","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-12","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-12","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:58c20d7717310668f09baa4b44806748d5f1a279efab2113219a3597af0f3366","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BOLT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526104121/bolt-20251231.htm","source_date":"2026-03-12T00:00:00+00:00","retrieved_at":"2026-05-15T23:49:32.940619+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-12T00:00:00+00:00","effective_from":"2026-03-12","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:12","subject_id":"alpha:company:839af13f-4847-4be6-a178-b529f6207475","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:william-p-quinn","object_label":"William P. Quinn","object_source_name_forms":[],"value":"William P. Quinn: President, Chief Executive Officer and Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:william-p-quinn","name":"William P. Quinn"},"title":"President, Chief Executive Officer and Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-12","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-12","valid_to":null,"recorded_at":"2026-10-16T13:53:41.002909+00:00","sources":[{"id":"alpha:projection-evidence:document:cbc4ae8ef667dcb810ba9d0421558abda09b08112a0d6bf9578d6b09eccd9710","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BOLT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526104121/bolt-20251231.htm","source_date":"2026-03-12T00:00:00+00:00","retrieved_at":"2026-05-15T23:49:32.483093+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-12T00:00:00+00:00","effective_from":"2026-03-12","effective_until":null,"observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Bolt Biotherapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000095017025058632/bolt-20250425.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:46:01.19+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:58c20d7717310668f09baa4b44806748d5f1a279efab2113219a3597af0f3366","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BOLT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526104121/bolt-20251231.htm","source_date":"2026-03-12T00:00:00+00:00","retrieved_at":"2026-05-15T23:49:32.940619+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:cbc4ae8ef667dcb810ba9d0421558abda09b08112a0d6bf9578d6b09eccd9710","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BOLT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526104121/bolt-20251231.htm","source_date":"2026-03-12T00:00:00+00:00","retrieved_at":"2026-05-15T23:49:32.483093+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.834,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.863,"cross_source_agreement":0.75,"temporal_completeness":0.583},"diagnostics":{"published_claims":19,"factual_claims":19,"claims_with_linked_evidence":19,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":12,"temporal_claims_with_valid_from":7,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:53:41.002909+00:00","observed_at":"2026-10-16T13:53:41.002909+00:00","reviewed_at":"2026-10-16T13:53:41.002909+00:00","verified_at":"2026-10-16T13:53:41.002909+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":19,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/bolt-biotherapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}